Back to Search Start Over

GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnostics

Authors :
A. J. Rodriguez-Morales
M. G. Rosa-Freitas
Guilherme S. Ribeiro
Nikos Vasilakis
Lisa F. P. Ng
Mariama Dalanda Diallo
Scott C. Weaver
Patrícia Brasil
Jan Felix Drexler
Johan Neyts
Anna-Bella Failloux
François Simon
Alain Kohl
A. Vega Rua
Maria Rios
Michael P. Busch
Michael S. Diamond
André Siqueira
Michael A. Drebot
P. Gallian
Sébastien Boyer
Ricardo Lourenço-de-Oliveira
Chantal Reusken
Angelle Desiree LaBeaud
Thomas Jaenisch
Marc Lecuit
Laura Pezzi
X. de Lamballerie
Graham Simmons
Amadou A. Sall
Unité des Virus Emergents (UVE)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire de Virologie [UNIV Corse-Inserm] (EA7310)
Université Pascal Paoli (UPP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
National Institute for Public Health and the Environment [Bilthoven] (RIVM)
Erasmus University Medical Center [Rotterdam] (Erasmus MC)
The University of Texas Medical Branch (UTMB)
Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
Humboldt University Of Berlin
Berlin Institute of Health (BIH)
German Centre for Infection Research (DZIF)
University of California [San Francisco] (UC San Francisco)
University of California (UC)
Stanford School of Medicine [Stanford]
Stanford Medicine
Stanford University-Stanford University
Washington University in Saint Louis (WUSTL)
Public Health Agency of Canada
Fundação Oswaldo Cruz / Oswaldo Cruz Foundation (FIOCRUZ)
Réseau International des Instituts Pasteur (RIIP)
Universidade Federal da Bahia (UFBA)
University of Glasgow
Biologie des Infections - Biology of Infection
Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Imagine - Institut des maladies génétiques (IMAGINE - U1163)
Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
CHU Necker - Enfants Malades [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Université Paris Descartes - Paris 5 (UPD5)
Agency for science, technology and research [Singapore] (A*STAR)
Etablissement Français du Sang - Alpes-Méditerranée (EFS - Alpes-Méditerranée)
Etablissement Français du Sang
Institut Pasteur du Cambodge
Institut Pasteur de Dakar
Arbovirus et Insectes Vecteurs - Arboviruses and Insect Vectors
Institut Pasteur [Paris] (IP)
Heidelberg University Hospital [Heidelberg]
Rega Institute for Medical Research [Leuven, België]
Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven)
U.S. Food and Drug Administration (FDA)
Universidad Tecnológica de Pereira [Colombie] (UTP)
Hôpital d'Instruction des Armées Laveran
Service de Santé des Armées
Institut Pasteur de la Guadeloupe
Publication fees were covered by the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pascal Paoli (UPP)
Humboldt-Universität zu Berlin
University of California [San Francisco] (UCSF)
University of California
Fundação Oswaldo Cruz (FIOCRUZ)
Institut Pasteur [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut Pasteur [Paris]
Virology
Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin
Humboldt Universität zu Berlin
Stanford University School of Medicine [Stanford]
Stanford University [Stanford]
Washington University in St Louis
Federal University of Bahia
Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Arbovirus et Insectes Vecteurs
Rega Institute for Medical Research
Source :
Antiviral Research, Antiviral Research, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, Antiviral Research, Elsevier Masson, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, ANTIVIRAL RESEARCH, Antiviral Research, 166, 66-81. Elsevier
Publication Year :
2019
Publisher :
HAL CCSD, 2019.

Abstract

The GloPID-R (Global Research Collaboration for Infectious Disease Preparedness) Chikungunya (CHIKV), O'nyong-nyong (ONNV) and Mayaro virus (MAYV) Working Group is investigating the natural history, epidemiology and medical management of infection by these viruses, to identify knowledge gaps and to propose recommendations for direct future investigations and rectification measures. Here, we present the first report dedicated to diagnostic aspects of CHIKV, ONNV and MAYV. Regarding diagnosis of the disease at the acute phase, molecular assays previously described for the three viruses require further evaluation, standardized protocols and the availability of international standards representing the genetic diversity of the viruses. Detection of specific IgM would benefit from further investigations to clarify the extent of cross-reactivity among the three viruses, the sensitivity of the assays, and the possible interfering role of cryoglobulinaemia. Implementation of reference panels and external quality assessments for both molecular and serological assays is necessary. Regarding sero-epidemiological studies, there is no reported high-throughput assay that can distinguish among these different viruses in areas of potential co-circulation. New specific tools and/or improved standardized protocols are needed to enable large-scale epidemiological studies of public health relevance to be performed. Considering the high risk of future CHIKV, MAYV and ONNV outbreaks, the Working Group recommends that a major investigation should be initiated to fill the existing diagnostic gaps. ispartof: ANTIVIRAL RESEARCH vol:166 pages:66-81 ispartof: location:Netherlands status: published

Details

Language :
English
ISSN :
01663542
Database :
OpenAIRE
Journal :
Antiviral Research, Antiviral Research, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, Antiviral Research, Elsevier Masson, 2019, 166, pp.66-81. ⟨10.1016/j.antiviral.2019.03.009⟩, ANTIVIRAL RESEARCH, Antiviral Research, 166, 66-81. Elsevier
Accession number :
edsair.doi.dedup.....64c66c9fe5a2697fd7854560c63ac589
Full Text :
https://doi.org/10.1016/j.antiviral.2019.03.009⟩